XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America.

Autor: Martínez CAA; Department of Interventional Cardiology, General Hospital 'Dr Miguel Silva', Morelia, Michoacán, Mexico., Lanas F; Departamento de Medicina Interna, Facultad de Medicina, Universidad de La Frontera, Temuco, Chile., Radaideh G; Department of Cardiology, Rashid Hospital, Dubai Health Authority, Dubai, United Arab Emirates., Kharabsheh SM; Department of Cardiovascular Diseases, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Lambelet M; Chrestos Concept GmbH & Co KG, Essen, Germany., Viaud MAL; Medical Affairs, Bayer AG, NJ, USA., Ziadeh NS; Medical Affairs, Bayer AG, Amman, Jordan., Turpie AGG; Department of Medicine, McMaster University, Hamilton, ON, Canada.

Publikováno v: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology [Egypt Heart J] 2018 Dec; Vol. 70 (4), pp. 307-313. Date of Electronic Publication: 2018 Sep 24.